Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong results driven by the strong demand of Lilly's blockbuster drugs, particularly recent launches. However, there are also concerns about potential pressures from ri